[HTML][HTML] Cutaneous connective tissue diseases: epidemiology, diagnosis, and treatment
BY Reddy, BM Hantash - The open dermatology journal, 2009 - ncbi.nlm.nih.gov
BY Reddy, BM Hantash
The open dermatology journal, 2009•ncbi.nlm.nih.govConnective tissue diseases (CTDs) are a group of clinical disorders that have an underlying
autoimmune pathogenesis. These include a diverse set of diseases such as relapsing
polychondritis, rheumatoid arthritis, and eosinophilic fasciitis, along with more common
entities like Sjogren's syndrome, dermatomyositis, scleroderma, and lupus erythematosus.
The latter three will be the focus of this review, as they constitute the most significant and
common CTD with cutaneous manifestations. The cutaneous signs often represent the …
autoimmune pathogenesis. These include a diverse set of diseases such as relapsing
polychondritis, rheumatoid arthritis, and eosinophilic fasciitis, along with more common
entities like Sjogren's syndrome, dermatomyositis, scleroderma, and lupus erythematosus.
The latter three will be the focus of this review, as they constitute the most significant and
common CTD with cutaneous manifestations. The cutaneous signs often represent the …
Abstract
Connective tissue diseases (CTDs) are a group of clinical disorders that have an underlying autoimmune pathogenesis. These include a diverse set of diseases such as relapsing polychondritis, rheumatoid arthritis, and eosinophilic fasciitis, along with more common entities like Sjogren’s syndrome, dermatomyositis, scleroderma, and lupus erythematosus. The latter three will be the focus of this review, as they constitute the most significant and common CTD with cutaneous manifestations. The cutaneous signs often represent the preliminary stages of disease and the presenting clinical symptoms. Therefore, comprehensive knowledge of CTD manifestations is essential for accurate diagnosis, better assessment of prognosis, and effective management. Although the precise etiologies of CTDs remain obscure, recent advances have allowed for further understanding of their pathogenesis and improved disease classifications. In addition, there have been developments in therapeutic options for CTDs. This review provides an overview of the epidemiology, clinical presentations, and current treatment options of cutaneous lupus erythematous, dermatomyositis and scleroderma.
ncbi.nlm.nih.gov
以上显示的是最相近的搜索结果。 查看全部搜索结果